Fine mapping and conditional analysis identify a new mutation in the autoimmunity susceptibility gene BLK that leads to reduced half-life of the BLK protein
Open Access
- 13 June 2012
- journal article
- research article
- Published by BMJ in Annals Of The Rheumatic Diseases
- Vol. 71 (7), 1219-1226
- https://doi.org/10.1136/annrheumdis-2011-200987
Abstract
Objectives To perform fine mapping of the autoimmunity susceptibility gene BLK and identify functional variants involved in systemic lupus erythematosus (SLE). Methods Genotyping of 1163 European SLE patients and 1482 controls and imputation were performed covering the BLK gene with 158 single-nucleotide polymorphisms. Logistic regression analysis was done using PLINK and conditional analyses using GENABEL's test score. Transfections of BLK constructs on HEK293 cells containing the novel mutation or the wild type form were analysed for their effect on protein half-life using a protein stability assay, cycloheximide and western blot. CHiP-qPCR for detection of nuclear factor κ B (NFkB) binding. Results Fine mapping of BLK identified two independent genetic effects with functional consequences: one represented by two tightly linked associated haplotype blocks significantly enriched for NFκB-binding sites and numerous putative regulatory variants whose risk alleles correlated with low BLK mRNA levels. Binding of NFkBp50 and p65 to an associated 1.2 Kb haplotype segment was confirmed. A second independent genetic effect was represented by an Ala71Thr, low-frequency missense substitution with an OR=2.31 (95% CI 1.38 to 3.86). The 71Thr decreased BLK protein half-life. Conclusions These results show that rare and common regulatory variants in BLK are involved in disease susceptibility and both, albeit independently, lead to reduced levels of BLK protein.This publication has 33 references indexed in Scilit:
- A haplotype map of the human genomeNature, 2005
- The UCSC Table Browser data retrieval toolNucleic Acids Research, 2004
- Multisite Phosphorylation by Cdk2 and GSK3 Controls Cyclin E DegradationMolecular Cell, 2003
- SIFT: predicting amino acid changes that affect protein functionNucleic Acids Research, 2003
- The non-receptor tyrosine kinase Syk is a target of Cbl-mediated ubiquitylation upon B-cell receptor stimulationThe EMBO Journal, 2001
- Human F-box protein hCdc4 targets cyclin E for proteolysis and is mutated in a breast cancer cell lineNature, 2001
- The Transcription Factor NF-κB/p50 Interacts with the blkGene during B Cell ActivationOnline Journal of Public Health Informatics, 1998
- Coordinated Regulation of the Tyrosine Phosphorylation of Cbl by Fyn and Syk Tyrosine KinasesOnline Journal of Public Health Informatics, 1998
- Specific Expression of a Tyrosine Kinase Gene, blk , in B Lymphoid CellsScience, 1990
- The 1982 revised criteria for the classification of systemic lupus erythematosusArthritis & Rheumatism, 1982